Home » Authors » Tiffany Turner

Tiffany Turner

Articles

ARTICLES

Middlebrook Gets $100M and a New Management Team

Nov. 1, 2011

By Tiffany Turner

No Abstract

IDM Pleased with Data from Osteosarcoma Program

Nov. 1, 2011

By Tiffany Turner

No Abstract

LigoCyte Sets Series C Terms: $28M for Vaccine Development

Nov. 1, 2011

By Tiffany Turner

No Abstract

NewCo News: Cortria Aims to Capitalize on Dyslipidemia Market

July 21, 2008

By Tiffany Turner

BioAlliance Stops Doxorubicin Trial After Pulmonary Reactions

July 17, 2008

By Tiffany Turner

Avastin, Tarceva Sales Boost Genentech's Quarterly Earnings

July 16, 2008

By Tiffany Turner

Neurogen Halts Dosing of Adipiplon in Insomnia

July 15, 2008

By Tiffany Turner

Big Pharmas Team Up to Link Technology and Business Needs

July 11, 2008

By Tiffany Turner

SGX Shares Soar on Merger Giving Lilly Technology Boost

July 10, 2008

By Tiffany Turner

Seattle Genetics Nets $4M in Deal with Daiichi Sankyo

July 9, 2008

By Tiffany Turner

View All Articles by Tiffany Turner

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...